Antifungal Activity of ZnO Nanoparticles and Nystatin and Downregulation of SAP1-3 Genes Expression in Fluconazole-Resistant Candida albicans Isolates from Vulvovaginal Candidiasis

References

• Ahmad A, Khan AU. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol. 2009;144(1):68–71. doi:10.1016/j.ejogrb.2008.12.02019261369
   PubMed Web of Science ®Google Scholar
• Monroy-Perez E, Paniagua-Contreras G, Vaca-Paniagua F, Negrete-Abascal E. SAP expression in Candida albicans strains isolated from Mexican patients with vaginal candidiasis. IJCM. 2013;4(1):25–33. doi:10.4236/ijcm.2013.41006
   Google Scholar
• Boros E, Pfliegler WP, Kovács R, Jakab Á. Candida albicans isolates from a single hospital show low phenotypical specialization. J Basic Microbiol. 2017;57(11):910–921. doi:10.1002/jobm.v57.1128891112
   PubMed Web of Science ®Google Scholar
• Wypij M, Czarnecka J, Dahm H, Rai M. Silver nanoparticles from Pilimelia columellifera subsp. Pallida SL19 strain demonstrated antifungal activity against fungi causing superficial mycoses. J Basic Microbiol. 2017;57(9):793–800. doi:10.1002/jobm.20170012128670763
   PubMed Web of Science ®Google Scholar
• Kadry AA, El-Ganiny AM, El-Baz AM. Relationship between Sap prevalence and biofilm formation among resistant clinical isolates of Candida albicans. Afr Health Sci. 2018;18(4):1166–1174. doi:10.4314/ahs.v18i4.3730766582
   PubMed Web of Science ®Google Scholar
• Yao D, Chen J, Chen W, Li Z. Mechanisms of azole resistance in clinical isolates of Candida glabrata from two hospitals in China. Infect Drug Resist. 2019;12:771–781. doi:10.2147/IDR.S20205831118695
   PubMed Web of Science ®Google Scholar
• Gu W, Guo D, Zhang L, Xu D. The synergistic effect of azoles and fluoxetine against resistant Candida albicans strains is attributed to attenuating fungal virulence. Antimicrob Agents Chemother. 2016;60(10):6179–6188. doi:10.1128/AAC.03046-1527503639
   PubMed Web of Science ®Google Scholar
• Copping VM, Barelle CJ, Hube B, Gow NA, Brown AJ, Odds FC. Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes. J Antimicrob Chemother. 2005;55(5):645–654. doi:10.1093/jac/dki08815820985
   PubMed Web of Science ®Google Scholar
• Martinez RC, Franceschini SA, Patta MC, Quintana SM. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol. 2009;48(3):269–274. doi:10.1111/j.1472-765X.2008.02477.x19187507
   PubMed Web of Science ®Google Scholar
• Sardella D, Gatt R, Valdramidis VP. Assessing the efficacy of zinc oxide nanoparticles against Penicillium expansum by automated turbidimetric analysis. Mycology. 2017;9(1):43–48. doi:10.1080/21501203.2017.136918730123660
   PubMedGoogle Scholar
• Shi XY, Yang YP, Zhang Y, et al. Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China. J Med Microbiol. 2015;64(4):390–393. doi:10.1099/jmm.0.00002425596116
   PubMed Web of Science ®Google Scholar
• Yano J, Sobel JD, Nyirjesy P, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019;19(1):48. doi:10.1186/s12905-019-0748-830925872
   PubMed Web of Science ®Google Scholar
• Mahmoudi Rad M, Zafarghandi S, Abbasabadi B, Tavallaee M. The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population. Eur J Obstet Gynecol Reprod Biol. 2011;155(2):199–203. doi:10.1016/j.ejogrb.2010.11.02221194828
   PubMed Web of Science ®Google Scholar
• Hosseini SS, Yadegari MH, Rajabibazl M, Ghaemi EA. Inhibitory effects of carvacrol on the expression of secreted aspartyl proteinases 1-3 in fluconazole-resistant Candida albicans isolates. Iran J Microbiol. 2016;8(6):401–409.28491252
   PubMedGoogle Scholar
• Esteban-Tejeda L, Prado C, Cabal B, Sanz J. Antibacterial and antifungal activity of ZnO containing glasses. PLoS One. 2015;10(7):e0136490. doi:10.1371/journal.pone.013270926295343
   PubMed Web of Science ®Google Scholar
• Morse DJ, Wilson MJ, Wei X, Bradshaw DJ. Modulation of Candida albicans virulence in in vitro biofilms by oral bacteria. Lett Appl Microbiol. 2019;68(4):337–343. doi:10.1111/lam.1314530825340
   PubMed Web of Science ®Google Scholar
• Kanathila H, Bhat AM, Krishna PD. Antifungal effect of magnesium oxide, zinc oxide, silicon oxide and copper oxide nanoparticles against Candida albicans. The effectiveness of magnesium oxide combined with tissue conditioners in inhibiting the growth of Candida albicans: an in vitro study. Indian J Dent Res. 2011;22(4):613. doi:10.4103/0970-9290.90324
   Google Scholar
• Ikonomova SP, Moghaddam-Taaheri P, Jabra-Rizk MA, Karlsson AJ. Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency. FEBS J. 2018;285:146–159. doi:10.1111/febs.1432729143452
   PubMed Web of Science ®Google Scholar
• Ollert MW, Sohnchen R, Korting HC, Ollert U. Mechanisms of adherence of C. albicans to cultured human epidermal Keratinocytes. Infect Immun. 1993;61(11):4560–4568. doi:10.1128/IAI.61.11.4560-4568.19938406852
   PubMed Web of Science ®Google Scholar
• Taylor BN, Staib P, Binder A, Biesemeier A. Profile of Candida albicans secreted aspartic proteinase elicited during vaginal infection. Infect Immun. 2005;73(3):1828–1835. doi:10.1128/IAI.73.3.1828-1835.200515731084
   PubMed Web of Science ®Google Scholar
• Lupetti A, Danesi R, Campa M, Del Tacca M. Molecular basis of resistance to azole antifungals. Trends Mol Med. 2002;8(2):76–81. doi:10.1016/S1471-4914(02)02280-311815273
   PubMed Web of Science ®Google Scholar
• Pam VK, Akpan JU, Oduyebo OO, et al. Fluconazole susceptibility and ERG11 gene expression in vaginal candida species isolated from Lagos Nigeria. Int J Mol Epidemiol Genet. 2012;3(1):84–90.22493755
   PubMedGoogle Scholar
• Abdullahi Nasir I, Uchenna E, Onyia J, Ifunanya AL. Prevalence of vulvovaginal candidiasis among nonpregnant women attending a tertiary health care facility in Abuja, Nigeria. Res Rep Trop Med. 2015;6:37–42.
   Google Scholar
• Hosseini SS, Roudbarmohammadi S, Joshaghani HR, Eskandari M. Antifungal effect of sodium dodecil sulfate and nanoparticle ZnO on the growth inhibition of standard strain of Candida albicans. J Gorgan Univ Med Sci. 2011;12(4):64–69.
   Google Scholar
• Ozcan SK, Budak F, Yucesoy G, Susever S, Willke A. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women. APMIS. 2006;114(2):139–145. doi:10.1111/apm.2006.114.issue-216519751
   PubMed Web of Science ®Google Scholar
• Cho O, Shiokama T, Ando Y, Aoki N. Screening of compounds from an FDA-approved drug library for the ability to inhibit aspartic protease secretion from the pathogenic yeast Candida albicans. Pharm Reg Affairs. 2014;3(5):1000126.
   Google Scholar
• Hosseini SS, Ghaemi E, Noroozi A, Niknejad F. Zinc oxide nanoparticles inhibition of initial adhesion and ALS1 and ALS3 gene expression in Candida albicans strains from urinary tract infections. Mycopathologia. 2019;184(2):261–271. doi:10.1007/s11046-019-00327-w30903582
   PubMed Web of Science ®Google Scholar
• Panácek A, Kolár M, Vecerová R, Prucek R. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials. 2009;30(31):6333–6340. doi:10.1016/j.biomaterials.2009.07.06519698988
   PubMed Web of Science ®Google Scholar
• Kiasat N, Rezaei-Matehkolaei A, Zarei Mahmoudabadi A, Hamidavi Mohamadpour K, Molavi S, Khoshayand N. Prevalence of Vulvovaginal candidiasis in Ahvaz, southwest Iran: a semi-large scale study. Jundishapur J Microbiol. 2019;12(3):1–6.
   Web of Science ®Google Scholar
• Hosseini SS, Ghaemi E, Koohsar F. Influence of ZnO nanoparticles on Candida albicans isolates biofilm formed on the urinary catheter. Iran J Microbiol. 2018;10(6):424–432.30873271
   PubMed Web of Science ®Google Scholar
• Cannon RD, Lamping E, Holmes AR, et al. Candida albicans drug resistance another way to cope with stress. Microbiology. 2007;153(Pt 10):3211–3217. doi:10.1099/mic.0.2007/010405-017906120
   PubMed Web of Science ®Google Scholar
• Akins RA. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol. 2005;43(4):285–318. doi:10.1080/1369378050013897116110776
   PubMed Web of Science ®Google Scholar